Liaocheng People's Hospital
Liaocheng People's Hospital
Liaocheng, Shandong, China16 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors | Advanced Solid Tumor Cancer | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT07847905 | |
| First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 | 2026-09-15 | NCT06730373 | |
| A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Not yet recruiting | Phase 3 | 2026-08-31 | NCT07795346 | |
| Pregnancy Salt Substitution Trial for Hypertensive Disorders of Pregnancy Prevention (PREG-Salt) | Hypertensive Disorders of Pregnancy | Recruiting | Not applicable | 2026-08-28 | NCT07294807 | |
| Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I) | cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-08-17 | NCT07587099 | |
| Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma | HER2 Negative; Low PD-L1 Expressing; Unresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma | Recruiting | Phase 2 | 2026-05-07 | NCT06932068 | |
| Normobaric Oxygen in AIS Transferred for EVT | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2025-12-11 | NCT06666764 | |
| Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis | brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Active, not recruiting | Phase 3 | 2025-11-25 | NCT06615726 | |
| Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients | Post-stroke Cognitive Impairment | Recruiting | Phase 2 | 2025-09-03 | NCT06315231 | |
| A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Not yet recruiting | Phase 3 | 2025-08-28 | NCT07146126 | |
| Study of LM-299 in Subjects Advanced Malignant Tumors | neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-05-02 | NCT06650566 | |
| A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 4 | 2025-01-24 | NCT05058040 | |
| Prospective Cohort of Patients With Intracerebral Hemorrhage | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stroke, Acute, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2024-11-01 | NCT06670456 | |
| A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Not stated | 2024-10-28 | NCT06662071 | |
| The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). | Type1 Diabetes Mellitus | Not yet recruiting | Not stated | 2024-09-23 | NCT06606509 | |
| Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome | Chronic Coronary Syndrome | Recruiting | Phase 4 | 2024-04-17 | NCT06171061 |